Zeureka wrote:However, that Zamboni did the ballooning on his own wife as the first patient in the history of CCSVI (and she wasn't at worst status of disability either) makes me think that he at least strongly believed the risk of ballooning in veins to be minimal. Stents is another issue...and also completely new issues (unfortunately like Ricci...I'm really sorry for this) may still occur.
But problems did not as yet, it seems, occur in Zambonis patients that only got ballooning. And this after some years now.
And of course, there's the issue as well that ballooning may not even be a satisfactory way to keep veins open, given the rate of failure for ballooning that seems to be happening in veins...
But I do respect that everyone has their own personal decision to make and we all may decide very differently what that decision will be in terms of treatment decisions for our MS.
I also have to add too though that in clinical trials, there is a LOT more information known than this about the testing and treatment that will be undertaken. It goes before an ethical review panel first as well. This doesn't even have animal model data and absolutely no blinded participants or doctors. There are a lot of missing factors in this that clinical trials don't have.